A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight loss — may also blunt the effects of alcohol. That might be bad news for casual drinkers, but ...

The GLP-1 market remains one of the great unknowns in food and beverage. That’s mostly because it really only entered the mainstream in the past five years. But, while it might be new to many, it’s ...

Please provide your email address to receive an email when new articles are posted on . GLP-1s may be the most cardioprotective glucose-lowering agents for patients with type 2 diabetes. Their effect ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...

Approximately one in eight Americans has taken a GLP-1 or glucagon-like peptide-1 receptor agonist. These medications were originally developed to help manage type 2 diabetes, but they also support ...

GLP-1 medications are no longer fringe – they’re mainstream, and they’re reshaping everything from public health to consumer behaviour. According to Kim Fisher, director of programs at the Institute ...

Please provide your email address to receive an email when new articles are posted on . Hidradenitis suppurativa is associated with repeat surgeries and hospitalizations. GLP-1 receptor agonist ...

GLP-1 medications like Ozempic and Wegovy are reducing users' appetites, leading to changes in dining habits. Some restaurants are beginning to adapt by offering smaller portions and specialized menus ...

Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with ...

New research reveals that popular GLP-1 medications like Ozempic could change how quickly alcohol affects the body, offering early clues into their surprising impact on craving, intoxication, and ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...